Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects
- Scott McGinnis,
- Tatsuo Kohriyama,
- Robert K. Yu,
- Michael A. Pesce,
- Norman Latov(corresponding author)
- New York Presbyterian Hospital,
- Yale University
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Serum of patients with neuropathy and IgM monoclonal antibodies (M-proteins) that bind to the myelin-associated glycoprotein (MAG) were tested for binding to the major cross-reactive sulfated glucuronic acid containing glycosphingolipid, sulfated glucuronic acid paragloboside (SGPG). IgM binding to the glycolipid was detectable at serum dilutions of 1 : 10 000 and reactivity was greatest at 4°C. Low titers of IgM binding to the glycolipid were also detected in sera from normal subjects and from patients with neurologic or rheumatologic diseases without serum M-proteins. Binding activity was prosent in 25% of the sera tested, and titers ranged between 1 : 25 and 1 : 400. One patient with peripheral neuropathy, however, had a measurable titer of 1 : 12 800 in the absence of monoclonal gammopathy. The study indicates that cold reacting anti-SGPG IgM antibodies are frequent constituents of the normal human antibody repertoire, and that monoclonal or polyclonal expansion of B cells that secrete these antibodies, is associated with peripheral neuropathy.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 119-126 (8 pages)Journal (Volume, Issue Number)
Journal of Neuroimmunology (Volume 17, Issue 2)Publication milestones
- Published - 01/1988
Publication status
ISSN
0165-5728Publication IDs
- Scopus: 0023815816
- PubMed: 2447123
